“Fumarate attenuated doxorubicin-induced cardiac injury through modulation of endothelial nitric oxide synthase expression and transforming growth factor-β1 signaling”, Prospect. Pharm. Sci., vol. 24, no. 2, pp. 52–59, Dec. 2025, doi: 10.56782/pps.677.